Eric E Niederkofler

Title: Eric E Niederkofler: Innovator in Lipid Metabolism

Introduction

Eric E Niederkofler is a notable inventor based in Phoenix, AZ (US). He has made significant contributions to the field of lipid metabolism through his innovative research and patent work. His expertise lies in developing methods to enhance lipoprotein lipase (LPL) activity, which is crucial for lipid metabolism.

Latest Patents

Niederkofler holds a patent for "Apolipoprotein C3 (ApoCIII) antagonists and methods of their use to remove ApoCIII inhibition of lipoprotein lipase (LPL)." This patent outlines methods for increasing LPL activity by inhibiting ApoCIII, thereby allowing for the conversion of VLDL to LDL. Additionally, it provides methods for treating or preventing lipid metabolism disorders, such as type 2 diabetes, through the use of ApoCIII antagonists. The patent also includes screening methods to identify potential ApoCIII antagonists.

Career Highlights

Niederkofler is associated with Imbp Holding, LLC, where he continues to advance his research in lipid metabolism. His work has the potential to impact the treatment of various metabolic disorders, showcasing his commitment to improving health outcomes.

Collaborations

He has collaborated with notable colleagues, including Urban A Kiernan and David A Phillips, to further his research initiatives. Their combined expertise enhances the potential for innovative solutions in the field of lipid metabolism.

Conclusion

Eric E Niederkofler is a pioneering inventor whose work in lipid metabolism is paving the way for new treatments and methods to address metabolic disorders. His contributions are significant in the ongoing quest to improve health through innovative scientific research.